tiprankstipranks
Trending News
More News >
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Financial Statements

Compare
93 Followers

Bone Biologics Financial Overview

Bone Biologics's market cap is currently $2.14M. The company's EPS TTM is $-4.865; its P/E ratio is -0.18; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -3.23M$ -4.22M$ -9.43M$ -3.67M$ -1.10M
EBITDA$ -3.23M$ 107.16K$ 479.57K$ -752.91K$ -805.58K
Net Income$ -3.11M$ -4.11M$ -8.95M$ -1.48M$ -1.61M
Balance Sheet
Cash & Short-Term Investments$ 5.33M$ 3.33M$ 3.03M$ 7.54M$ 6.68M
Total Assets$ 5.80M$ 3.86M$ 3.74M$ 8.50M$ 6.68M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -5.33M$ -3.33M$ -3.03M$ -7.54M$ -6.68M
Total Liabilities$ 418.59K$ 377.71K$ 831.40K$ 2.55M$ 99.91K
Stockholders' Equity$ 5.38M$ 3.48M$ 2.91M$ 5.95M$ 6.58M
Cash Flow
Free Cash Flow$ -2.69M$ -4.12M$ -9.56M$ -3.57M$ -1.23M
Operating Cash Flow$ -2.69M$ -4.12M$ -9.56M$ -3.57M$ -1.23M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 4.70M$ 4.42M$ 5.04M$ 4.43M$ 7.90M
Currency in USD

Bone Biologics Earnings and Revenue History

Bone Biologics Debt to Assets

Bone Biologics Cash Flow

Bone Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.